Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Japan · Delayed Price · Currency is JPY

2,016.00

+34.00 (1.72%)

Sep 14, 2026, 3:30 PM JST

Market Cap	88.86B -4.1%
Revenue (ttm)	91.12B +6.8%
Net Income	8.23B +20.8%
EPS	186.70 +20.8%
Shares Out	44.08M
PE Ratio	10.80
Forward PE	8.42
Dividend	50.00 (2.51%)
Ex-Dividend Date	Sep 29, 2026

Volume	171,500
Open	1,995.00
Previous Close	1,982.00
Day's Range	1,988.00 - 2,016.00
52-Week Range	1,878.00 - 2,434.00
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and e... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1955

Employees 1,748

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4559

Full Company Profile

Financial Performance

In fiscal year 2026, Zeria Pharmaceutical's revenue was 89.16 billion, an increase of 2.12% compared to the previous year's 87.31 billion. Earnings were 8.45 billion, a decrease of -14.92%.

Financial Statements